Global AI in Biopharmaceutical Development Market, by Type
Global AI in Biopharmaceutical Development Market, by Application
Global AI in Biopharmaceutical Development Market, by End-User
Global AI in Biopharmaceutical Development Market, by Region
North America AI in Biopharmaceutical Development Market , by Country
Europe AI in Biopharmaceutical Development Market , by Country
Asia Pacific AI in Biopharmaceutical Development Market , by Country
Latin America AI in Biopharmaceutical Development Market , by Country
Middle East & Africa AI in Biopharmaceutical Development Market , by Country
Competitive Landscape
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global AI in Biopharmaceutical Development Market Snapshot
Chapter 4. Global AI in Biopharmaceutical Development Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis of AI Industry
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact on Metaverse Industry
Chapter 5. Market Segmentation 1: By Type Estimates & Trend Analysis
5.1. By Type & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Type:
5.2.1. Monoclonal antibodies
5.2.2. Vaccines
5.2.3. Recombinant proteins
Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. By Application & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Technology Type:
6.2.1. Research and discovery
6.2.2. Clinical development
6.2.3. Manufacturing & supply chain and other subsegments
Chapter 7. Market Segmentation 3: By End-User Estimates & Trend Analysis
7.1. By End-user & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-user:
7.2.1. Biopharmaceutical manufacturers
7.2.2. Contract manufacturing organizations (CMOs) or contract research organizations (CROs)
7.2.3. Academic & government research institutes
Chapter 8. AI in Biopharmaceutical Development Market Segmentation 4 : Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America AI in Biopharmaceutical Development Market revenue (US$ Million) estimates and forecasts by Type, 2021-2034
8.1.2. North America AI in Biopharmaceutical Development Market revenue (US$ Million) estimates and forecasts by Application, 2021-2034
8.1.3. North America AI in Biopharmaceutical Development Market revenue (US$ Million) estimates and forecasts by End-user, 2021-2034
8.1.4. North America AI in Biopharmaceutical Development Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
8.1.4.1. U.S.
8.1.4.2. Canada
8.2. Europe
8.2.1. Europe AI in Biopharmaceutical Development Market revenue (US$ Million) by by Type, 2021-2034
8.2.2. Europe AI in Biopharmaceutical Development Market revenue (US$ Million) estimates and forecasts by Application, 2021-2034
8.2.3. Europe AI in Biopharmaceutical Development Market revenue (US$ Million) estimates and forecasts by End-user, 2021-2034
8.2.4. Europe AI in Biopharmaceutical Development Market revenue (US$ Million) by country, 2021-2034
8.2.4.1. Germany
8.2.4.2. Poland
8.2.4.3. France
8.2.4.4. Italy
8.2.4.5. Spain
8.2.4.6. UK
8.2.4.7. Rest of Europe
8.3. Asia Pacific
8.3.1. Asia Pacific AI in Biopharmaceutical Development Market revenue (US$ Million) by by Type, 2021-2034
8.3.2. Asia Pacific AI in Biopharmaceutical Development Market revenue (US$ Million) estimates and forecasts by Application, 2021-2034
8.3.3. Asia Pacific AI in Biopharmaceutical Development Market revenue (US$ Million) estimates and forecasts by End-user, 2021-2034
8.3.4. Asia Pacific AI in Biopharmaceutical Development Market revenue (US$ Million) by country, 2021-2034
8.3.4.1. China
8.3.4.2. India
8.3.4.3. Japan
8.3.4.4. Australia
8.3.4.5. Rest of Asia Pacific
8.4. Latin America
8.4.1. Latin America AI in Biopharmaceutical Development Market revenue (US$ Million) by Type, 2021-2034
8.4.2. Latin America AI in Biopharmaceutical Development Market revenue (US$ Million) estimates and forecasts by Application, 2021-2034
8.4.3. Latin America AI in Biopharmaceutical Development Market revenue (US$ Million) estimates and forecasts by End-user, 2021-2034
8.4.4. Latin America AI in Biopharmaceutical Development Market revenue (US$ Million) by country, (US$ Million) 2021-2034
8.4.4.1. Brazil
8.4.4.2. Rest of Latin America
8.5. Middle East & Africa
8.5.1. Middle East & Africa AI in Biopharmaceutical Development Market revenue (US$ Million) by Type, 2021-2034
8.5.2. Middle East & Africa AI in Biopharmaceutical Development Market revenue (US$ Million) estimates and forecasts by Application, 2021-2034
8.5.3. Middle East & Africa AI in Biopharmaceutical Development Market revenue (US$ Million) estimates and forecasts by End-user, 2021-2034
8.5.4. Middle East & Africa AI in Biopharmaceutical Development Market revenue (US$ Million) by country, (US$ Million) 2021-2034
8.5.4.1. South Africa
8.5.4.2. GCC Countries
8.5.4.3. Rest of MEA
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. IBM Watson Health
9.2.2. Google (Alphabet Inc.)
9.2.3. Concreto HealthAI
9.2.4. Nvidia Corporation
9.2.5. PathAI
9.2.6. Atomwise, Inc.
9.2.7. Deep Genomics
9.2.8. Cloud Pharmaceuticals, Inc.
9.2.9. Ai-biopharma S.A.S.
9.2.10. Microsoft Corporation
9.2.11. Other Prominent Players
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.